TREATMENT OF RELAPSED ACUTE MYELOCYTIC-LEUKEMIA WITH A COMBINATION OF ACLARUBICIN AND CYTOSINE-ARABINOSIDE

被引：0
|
作者：
TAKAHASHI, I
HARA, M
UCHIDA, K
TAKAOKA, K
WATANABE, S
LAI, M
HAMASAKI, K
KOHI, F
KITAJIMA, K
KIMURA, I
ADACHI, T
YORIMITSU, S
TOKIOKA, M
SANADA, H
机构：
[1] OKAYAMA CITY HOSP, DEPT MED, OKAYAMA 700, JAPAN
[2] EHIME CENT HOSP, DEPT MED, MATSUYAMA 790, JAPAN
[3] OKAYAMA NATL HOSP, DEPT MED, OKAYAMA 700, JAPAN
[4] OKAYAMA UNIV, SCH MED, DEPT CENT LAB, OKAYAMA 700, JAPAN
来源：
ACTA MEDICA OKAYAMA | 1982年 / 36卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：77 / 80
页数：4
相关论文
共 50 条
  • [1] VINBLASTINE, PROCARBAZINE, AND CYTOSINE-ARABINOSIDE IN COMBINATION FOR REINDUCTION OF CHILDHOOD ACUTE MYELOCYTIC-LEUKEMIA
    RAMSAY, NKC
    COCCIA, PF
    KRIVIT, W
    BLOOMFIELD, CD
    NESBIT, ME
    CANCER TREATMENT REPORTS, 1976, 60 (11): : 1683 - 1685
  • [2] COMBINATION OF RUBIDAZONE AND CYTOSINE-ARABINOSIDE IN THE TREATMENT OF 1ST RELAPSE IN ACUTE MYELOCYTIC-LEUKEMIA
    PAVLOVSKY, S
    FERNANDEZ, I
    PALAU, V
    SANTARELLI, MT
    DEBELLIS, R
    RUIZARGUELLES, G
    BRANDALISE, S
    JIMENEZFONSECA, E
    ANNALS OF ONCOLOGY, 1991, 2 (06) : 441 - 442
  • [3] COMPARATIVE TRIAL OF DAUNORUBICIN, CYTOSINE-ARABINOSIDE, AND THIOGUANINE, AND A COMBINATION OF THE 3 AGENTS FOR THE TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA
    WIERNIK, PH
    GLIDEWELL, OJ
    HOAGLAND, HC
    BRUNNER, KW
    SPURR, CL
    CUTTNER, J
    SILVER, RT
    CAREY, RW
    DELDUCA, V
    KUNG, FH
    HOLLAND, JF
    MEDICAL AND PEDIATRIC ONCOLOGY, 1979, 6 (03): : 261 - 277
  • [4] INVIVO DEVELOPMENT OF CYTOSINE-ARABINOSIDE RESISTANCE IN THE BN ACUTE MYELOCYTIC-LEUKEMIA
    HAGENBEEK, A
    MARTENS, ACM
    COLLY, LP
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 202 - 206
  • [5] SEQUENTIAL INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE FOR PATIENTS WITH RELAPSED AND REFRACTORY ACUTE MYELOCYTIC-LEUKEMIA
    PACIUCCI, PA
    CUTTNER, J
    HOLLAND, JF
    AMERICAN JOURNAL OF HEMATOLOGY, 1990, 35 (01) : 22 - 25
  • [6] CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN OR ADRIAMYCIN FOR THERAPY OF ACUTE MYELOCYTIC-LEUKEMIA - A CALGB STUDY
    YATES, J
    GLIDEWELL, O
    WIERNIK, P
    COOPER, MR
    STEINBERG, D
    DOSIK, H
    LEVY, R
    HOAGLAND, C
    HENRY, P
    GOTTLIEB, A
    CORNELL, C
    BERENBERG, J
    HUTCHISON, JL
    RAICH, P
    NISSEN, N
    ELLISON, RR
    FRELICK, R
    JAMES, GW
    FALKSON, G
    SILVER, RT
    HAURANI, F
    GREEN, M
    HENDERSON, E
    LEONE, L
    HOLLAND, JF
    BLOOD, 1982, 60 (02) : 454 - 462
  • [7] ACLARUBICIN IN THE TREATMENT OF DENOVO ACUTE MYELOCYTIC-LEUKEMIA
    LABAR, B
    NEMET, D
    MINIGO, H
    BOGDANIC, V
    JAKSIC, B
    MALESEVIC, M
    MRSIC, M
    BONE MARROW TRANSPLANTATION, 1989, 4 : 45 - 46
  • [8] CHEMOTHERAPY FOR ACUTE MYELOCYTIC-LEUKEMIA (AML) WITH CYTOSINE-ARABINOSIDE (ARA-C) AND ADRIAMYCIN (ADR)
    PREISLER, HD
    BJORNSSON, S
    HENDERSON, ES
    BLOOD, 1976, 48 (06) : 982 - 982
  • [9] SUBCUTANEOUS CYTOSINE-ARABINOSIDE IS SUPERIOR TO INTRAVENOUS ROUTE IN REMISSION MAINTENANCE THERAPY OF ACUTE MYELOCYTIC-LEUKEMIA
    RAI, KR
    GLIDEWELL, O
    MCINTYRE, OR
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 407 - 407
  • [10] TREATMENT OF ACUTE MYELOID LEUKEMIA WITH CYTOSINE-ARABINOSIDE AND DAUNOMYCIN IN COMBINATION
    BRINCKER, H
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1972, 9 (06): : 657 - &
12345